Attached files
| file | filename |
|---|---|
| EX-10.5 - EX-10.5 - Metacrine, Inc. | d877486dex105.htm |
| EX-10.4 - EX-10.4 - Metacrine, Inc. | d877486dex104.htm |
| EX-10.3 - EX-10.3 - Metacrine, Inc. | d877486dex103.htm |
| EX-5.1 - EX-5.1 - Metacrine, Inc. | d877486dex51.htm |
| EX-4.1 - EX-4.1 - Metacrine, Inc. | d877486dex41.htm |
| EX-3.1 - EX-3.1 - Metacrine, Inc. | d877486dex31.htm |
| EX-1.1 - EX-1.1 - Metacrine, Inc. | d877486dex11.htm |
| S-1/A - S-1/A - Metacrine, Inc. | d877486ds1a.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated July 2, 2020 (except for the last paragraph of Note 9, as to which the date is September 9, 2020) in Amendment No. 1 to the Registration Statement on Form S-1 (No. 333-248292) and the related Prospectus of Metacrine, Inc. for the registration of shares of its common stock.
/s/ Ernst & Young LLP
San Diego, California
September 9, 2020